[Difficulties and prospects in the immunotherapy of gliomas].

In conclusion, although the CNS is not any more considered as an "immunological sanctuary" and despite some encouraging experimental and clinical results in CNS oncotherapy, the routine application of IT in case of MGs is still awaited.
PMID: 31533142 [PubMed - in process]

Source: Magyar Onkologia - September 17, 2019 Category: Cancer & Oncology Authors: Mangel L, Najbauer J, Kajtár B, Pongrácz EJ Tags: Magy Onkol Source Type: research